Trial intelligence / Profile preview

Glufosfamide in advanced soft tissue sarcoma

NCT00441467Phase 2Completed

Sponsor
Eleison Pharmaceuticals
Start
Mar 2007
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of glufosfamide in soft tissue sarcoma (STS), sponsored by Eleison Pharmaceuticals. Started Mar 2007; status: completed.

02

Drugs

glufosfamide
03

Conditions

soft tissue sarcoma (STS)

Beyond the preview

Go deeper on NCT00441467.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00441467.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call